COPD in nonsmokers;EPOC en individuos no fumadores

Archivos de Bronconeumologia

Volumn 46, Issue SUPPL. 4, 2010, Pages 16-21

  Rubio, Myriam Calle ^a   Rodríguez Hermosa, Juan Luis ^a   Álvarez Sala Walther, José Luis ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Environmental pollution; Nonsmokers; Occupational exposure

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID;

AIR POLLUTION; ARTICLE; ASTHMA; CAUSAL ATTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; LUNG TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PREVALENCE; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS;

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 77957655945     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(10)70028-4     Document Type: Article

References (45)

1. Global Initiative for Chronic Obstructive Lung Disease Executive summary: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. [Accedido May de 2010]. Updated diciembre 2009. Disponible en: http://www.goldcopd.com/.
2. Peces-Barba G, Barberá JA, Agustí A, Casanova C, Casas A, Izquierdo JL, et al. Guía de práctica clínica de diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica SEPAR-ALAT, 2009. [Accedido Feb de 2010]. Disponible en: http://www.separ.es/.
3. Alvarez-Sala J.L., Cimas E., Masa J.F., Miravitlles M., Molina J., Naberan K., et al. Recomendaciones para la atención al paciente con enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001, 37:269-278.
4. Shirtcliffe P., Weatherall M., Marsh S., Travers J., Hansell A., McNaughton A., et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007, 30:232-239.
5. Liu S., Zhou Y., Wang X., Wang D., Lu J., Zheng J., et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 2007, 62:889-897.
6. Zhou Y., Wang C., Yao W., Chen P., Kang J., Huang S., et al. COPD in Chinese nonsmokers. Eur Respir J 2009, 33:509-518.
7. Caballero A., Torres-Duque C.A., Jaramillo C., Bolívar F., Sanabria F., Osorio P., et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest 2008, 133:343-349.
8. Menezes A.M., Pérez-Padilla R., Jardim J.R., Muiño A., Lopez M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881.
9. Gunen H., Hacievliyagil S.S., Yetkin O., Gulbas G., Mutlu L.C., Pehlivan E. Prevalence of COPD: first epidemiological study of a large region in Turkey. Eur J Intern Med 2008, 19:499-504.
10. Kim D.S., Kim Y.S., Jung K.S., Chang J.H., Lim C.M., Lee J.H., et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005, 172:842-847.
11. Lindberg A., Jonsson A.C., Rönmark E., Lundgren R., Larsson L.G., Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration 2005, 72:471-479.
12. Viegi G., Pedreschi M., Pistelli F., Di Pede F., Baldacci S., Carrozzi L., et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000, 117(Suppl 2):339S-345S.
13. Peña V.S., Miravitlles M., Gabriel R., Jiménez-Ruiz C.A., Villasante C., Masa J.F., et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000, 118:981-989.
14. Ancochea J., Badiola C., Duran-Tauleria E., Garcia Rio F., Miravitlles M., Muñoz L., et al. Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España. Arch Bronconeumol 2009, 45:41-47.
15. Behrendt C.E. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005, 128:1239-1244.
16. Buist A.S., Vollmer W.M., McBurnie M.A. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 2008, 12:703-708.
17. Salvi S.S., Barnes P.J. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009, 374:733-743.
18. Lundbäck B., Lindberg A., Lindström M., Rönmark E., Jonsson A.C., Jönsson E., et al. Not 15 but 50% of smokers develop COPD? -Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003, 97:115-122.
19. Ramírez-Venegas A., Sansores R.H., Pérez-Padilla R., Regalado J., Velázquez A., Sánchez C., et al. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006, 173:393-397.
20. Shavelle R.M., Paculdo D.R., Kush S.J., Mannino D.M., Strauss D.J. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III follow-up study. Int J Chron Obstruct Pulmon Dis 2009, 4:137-148.
21. Moran-Mendoza O., Pérez-Padilla J.R., Salazar-Flores M., Vázquez-Alfaro F. Wood smoke-associated lung disease: a clinical, functional, radiological and pathological description. Int J Tuberc Lung Dis 2008, 12:1092-1098.
22. Joost O., Wilk J.B., Cupples L.A., Harmon M., Shearman A.M., Baldwin C.T., et al. Genetic loci influencing lung function: a genome-wide scan in the Framingham Study. Am J Respir Crit Care Med 2002, 165:795-799.
23. Joos L., Paré P.D., Sandford A.J. Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med Wkly 2002, 132:27-37.
24. McCloskey S.C., Patel B.D., Hinchliffe S.J., Reid E.D., Wareham N.J., Lomas D.A. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001, 164:1419-1424.
25. Silverman E.K., Palmer L.J., Mosley J.D., Barth M., Senter J.M., Brown A., et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002, 70:1229-1239.
26. Vidal R., Blanco I., Casas F., Jardí R., Miravitlles M. Diagnóstico y tratamiento del déficit de alfa-1-antitripsina. Arch Bronconeumol 2006, 42:645-659.
27. Sandford A.J., Chagani T., Weir T.D., Connett J.E., Anthonisen N.R., Paré P.D. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001, 163:469-473.
28. Hirano K., Sakamoto T., Uchida Y., Morishima Y., Masuyama K., Ishii Y., et al. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2001, 18:748-752.
29. Soriano J.B., Maier W.C., Egger P., Visick G., Thakrar B., Sykes J., et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000, 55:789-794.
30. Fletcher C., Peto R. The natural history of chronic airflow obstruction. Br Med J 1977, 1:1645-1648.
31. Antó J.M., Vermeire P., Vestbo J., Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001, 17:982-994.
32. Viegi G., Scognamiglio A., Baldacci S., Pistelli F., Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001, 68:4-19.
33. Fairbairn A.S., Reid D.D. Air pollution and other local factors in respiratory disease. Br J Prev Soc Med 1958, 12:94-103.
34. Ackermann-Liebrich U., Leuenberger P., Schwartz J., Schindler C., Monn C., Bolognini G., et al. Lung function and long term exposure to air pollutants in Switzerland. Am J Respir Crit Care Med 1997, 155:122-129.
35. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004, 328:1519.
36. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
37. Sood A., Petersen H., Blanchette C., Meek P., Belinsky S., Picchi M., et al. Wood smoke-associated chronic obstructive pulmonary disease (COPD) -Underappreciated in the United States?. Am J Respir Crit Care Med 2009, 179:A4742.
38. Po J.Y., Shahidi N., FitzGerald J.M., Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Am J Respir Crit Care Med 2009, 179:A4740.
39. Hancox R.J., Poulton R., Greene J.M., McLachlan C.R., Pearce M.S., Sears M.R. Associations between birth weight, early childhood weight gain and adult lung function. Thorax 2009, 64:228-232.
40. Balmes J., Becklake M., Blanc P., Henneberger P., Kreiss K., Mapp C., et al. Environmental and Occupational Health Assembly. American Thoracic SocietyAmerican Thoracic Society statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003, 167:787-797.
41. Vineis P., Airoldi L., Veglia F., Olgiati L., Pastorelli R., Autrup H., et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 2005, 330:277.
42. Lamprecht B., Schirnhofer L., Kaiser B., Studnicka M., Buist A.S. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study. Am J Ind Med 2007, 50:421-426.
43. Eduard W., Pearce N., Douwes J. Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest 2009, 136:716-725.
44. Weinmann S., Vollmer W.M., Breen V., Heumann M., Hnizdo E., Villnave J., et al. COPD and occupational exposures: a case-control study. J Occup Environ Med 2008, 50:561-569.
45. Hegewald M.J., Crapo R.O. Socioeconomic status and lung function. Chest 2007, 132:1608-1614.